Hello, Guest
Login
Sign Up
 
 

Hot Morning Movers: Advaxis (OTC:ADXS), Growlife (OTC:PHOT), AMARANTUS BIOSCI (OTC:AMBS)

 
 
Repost This

Stamford, CT -- (SBWIRE) -- 02/22/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on Best Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.

Advaxis, Inc. (OTC:ADXS) went up in its current trading session, its current trading price is $0.131 whereas its today’s opening price was $0.12. Shares of ADXS are trading with the volume of 2.35 million shares while its average volume is 6.78 million shares.

Can ADXS Show a Strong Recovery? Find out in This Research Report

Its overall performance for last 5 days is remained positive with the gain of +8.33% whereas its year to date performance is upward with the gain of +333.33%. 52 week price range of the company is $0.03 - $0.16.Advaxis, Inc. (OTC:ADXS) recently announced that the Brown University Oncology Research Group (BrUOG) will be coordinating a Phase 1/2 study of ADXS-HPV in 25 patients with HPV-associated anal cancer. Dr. Howard Safran, professor of medicine, will be principal investigator.

How Should Investors Trade ADXS Now? Don’t Miss out a Special Trend Analysis

Growlife Inc (OTC:PHOT) reported upward trend in early market hours it gained +6.67% recently with the total traded volume of 3.41 million shares whereas its average volume is 12.87 million shares company’s 52 week price range is $0.01 - $0.25. Its today’s opening price was $0.06 and up till now its highest price was $0.06. Company’s year to date performance is optimistic with an upsurge of +72.97%.

Should PHOT a Buy or Sell Now? Find Out Here

Company’s previous 6 months trend remained positive as it scored more than +190.91%. But if we look at last three month that it was up with the gain of +54.22%.

AMARANTUS BIOSCI INC (OTC:AMBS) started its trade with downward momentum and down till now its movement was declining with the drop of -6.25% today’s opening price of the shares was $0.06 and recent trading volume was 2.00 million shares. Average volume of the shares was 11.36 million.

What AMBS’s Charts Are Signaling for Traders? Find Out Here

If we look at previous 5 days trend overall it was declining with the plunge of -28.32%, whereas overall in last one month company’s performance was downward with the loss of more than -37.82%. AMBS’s total market capitalization stands at $14.35 million.

AMARANTUS BIOSCI INC has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson’s disease, Traumatic Brain Injury and other human diseases.

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.